Does Medicaid Cover GLP-1 Medications?

Medicaid coverage for GLP-1 medications varies by state and specific drug formulation. State Medicaid programs generally cover GLP-1 medications prescribed for diabetes, although prior authorization and other requirements vary. Metformin and insulin are diabetes treatments, but they are not GLP-1 medications. However, coverage for obesity treatment remains limited. As of January 2026, 13 state Medicaid fee-for-service programs covered at least one GLP-1 medication for obesity, and coverage continues to change. Prior authorization requirements vary by state and may include a BMI threshold, documentation of related health conditions, or a history of previous weight-management treatment. Diabetes is not always required. Coverage depends on the specific product and the condition it is prescribed to treat. Ozempic and Mounjaro are approved for type 2 diabetes, while Wegovy and Zepbound are approved for chronic weight management; generic options are limited and are not interchangeable with every brand. Contact your state Medicaid office or pharmacy to verify specific coverage for your prescribed medication and indication.